Regulation of melanocyte apoptosis by Stathmin 1 expression

Journal of Biochemistry and Molecular Biology

Volumn 41, Issue 11, 2008, Pages 765-770

  Zhang, Yan ^a,b   Xiong, Jianjun ^a   Wang, Jiali ^a   Shi, Xianping ^a   Bao, Guodong ^b   Zhang, Yang ^b   Zhu, Zhenyu ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Melanin; Pigmentation; Programmed cell death; RNA interference; Tyrosinase

Indexed keywords

EID: 56649085320     PISSN: 12258687     EISSN: 02191024     Source Type: Journal    
DOI: 10.5483/bmbrep.2008.41.11.765     Document Type: Article

References (25)

1. Westerhof, W. (2006) The discovery of the human melanocyte. Pigment Cell Res. 19, 183-193.
2. Grant, W.B., Strange, R.C. and Garland, C.F. (2003) Sunshine is good medicine. The health benefits of ultraviolet-B induced vitamin D production. J. Cosmet. Dermatol. 2, 86-98.
3. Liu A, Stadelmann C, Moscarello M, Bruck W, Sobel A, Mastronardi FG, Casaccia-Bonnefil P. (2005) Expression of Stathmin, a Developmentally Controlled Cytoskeleton-Regulating Molecule, in Demyelinating Disorders. J. Neurosci. 3, 737-747.
4. Rubin, C.I. and Atweh, G.F. (2004) The Role of Stathmin in the Regulation of the Cell Cycle. Atweh Journal of Cellular Biochemistry. 93, 242-250.
5. Mistry, S.J. and Atweh, G.F. (2002). Role of stathmin in the regulation of the mitotic spindle: potential applications in cancer therapy. Mt Sinai J. Med. 5, 299-304.
6. Toda T, Sugimoto M, Omori A, Matsuzaki T, Furuichi Y, Kimura N. (2000) Proteomic analysis of Epstein-Barr virus transformed human B-lymphoblastoid cell lines before and after immortalization. Electrophoresis. 21, 1814-1822.
7. Hayashi K, Pan Y, Shu H, Ohshima T, Kansy JW, White CL 3rd, Tamminga CA, Sobel A, Curmi PA, Mikoshiba K, Bibb JA. (2006) Phosphorylation of the tubulin-binding protein, stathmin, by Cdk5 and MAP kinases in the brain. J. Neurochem. 1, 237-250.
8. Mizumura K, Takeda K, Hashimoto S, Horie T, Ichijo H. (2006) Identification of Op18/stathmin as a potential target of ASK1-p38 MAP kinase cascade. J. Cell Physiol. 2, 363-370.
9. Marklund U, Larsson N, Gradin HM, Brattsand G, Gullberg M. (1996) Oncoprotein 18 is a phosphorylation-responsive regulator of microtubule dynamics. The EMBO Journal. 19, 5290-5298.
10. Gradin HM, Larsson N, Marklund U, Gullberg M. (1998) Regulation of microtubule dynamics by extracellular signals: cAMP-dependent protein kinase switches off the activity of oncoprotein 18 in intact cells. J. Cell Biol. 1, 131-141.
11. Belmont, L.D. and Mitchison, T.J. (1996). Identification of a protein that interacts with tubulin dimers and increases the catastrophe rate of microtubules. Cell. 4, 623-631.
12. Jourdain, L., Curmi, P. and Sobel, A. (1997). Stathmin: a tubulin-sequestering protein which forms a ternary T2S complex with two tubulin molecules. Biochemistry 36, 10817-10821.
13. Caldwell BD, Darlington DN, Penzes P, Johnson RC, Eipper BA, Mains RE. (1999) The novel kinase peptidylglycine alpha-amidating monooxygenase cytosolic interactor protein 2 interacts with the cytosolic routing determinants of the peptide processing enzyme peptidylglycine alpha- amidating monooxygenase. J. Biol. Chem. 49, 34646-34656.
14. Bièche I, Manceau V, Curmi PA, Laurendeau I, Lachkar S, Leroy K, Vidaud D, Sobel A, Maucuer A. (2003) Quantitative RT-PCR reveals a ubiquitous but preferentially neural expression of the KIS gene in rat and human. Molecular Brain Research. 114, 55-64.
15. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498.
16. Kim, J., Kim, H., Lee, Y., Yang, K., Byun, S. and Han, K. (2006) A Simple and Economical Short-oligonucleotide-based Approach to shRNA Generation. JBMB. 39, 329-334
17. Sui G, Soohoo C, Affar el B, Gay F, Shi Y, Forrester WC, Shi Y. (2002) A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 99, 5515-5520.
18. Hunt, G. and Thody, A.J. (1995) Agouti protein can act independently of melanocyte-stimulating hormone to inhibit melanogenesis. J. Endocrinol. 2, R1-4.
19. Nakajima M, Shinoda I, Fukuwatari Y, Hayasawa H. (1998) Arbutin increases the pigmentation of cultured human melanocytes through mechanisms other than the induction of tyrosinase activity. Pigment Cell Res. 1, 12-17.
20. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VM. (1995) Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81, 801-809.
21. Hirobe, T., Wakamatsu, K. and Ito, S. (2006) The slaty mutation affects eumelanin and pheomelanin synthesis in mouse melanocytes. European Journal of Cell Biology. 85, 537-549.
22. Martin, S.E. and Caplen, N.J. (2006) Mismatched siRNAs downregulate mRNAs as a function of target site location. FEBS Lett. 15, 3694-3698.
23. Prabhu, R., Garry, R.F. and Dash, S. (2006) Small interfering RNA targeted to stem-loop II of the 5′ untranslated region effectively inhibits expression of six HCV genotypes. Virol J. 3, 100.
24. Mistry, S.J., Bank, A. and Atweh, G.F. (2005) Targeting stathmin in prostate cancer. Mol Cancer Ther. 12, 1821-1829.
25. Iancu-Rubin, C., Nasrallah, C.A. and Atweh, G.F. (2005) Stathmin prevents the transition from a normal to an endomitotic cell cycle during megakaryocytic differentiation. Cell Cycle. 12, 1774-1782.